Profil
Ram Kamineni is currently working as the Senior VP-CMC & Technical Operations at Krystal Biotech, Inc. Prior to this role, he worked as the Chief Operating Officer at KVK-Tech, Inc.
Aktive Positionen von Ram Kamineni
Unternehmen | Position | Beginn |
---|---|---|
KRYSTAL BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 01.07.2022 |
Ehemalige bekannte Positionen von Ram Kamineni
Unternehmen | Position | Ende |
---|---|---|
KVK-Tech, Inc.
KVK-Tech, Inc. Pharmaceuticals: MajorHealth Technology KVK-Tech, Inc. is a pharmaceutical company based in the United States, specifically in Newtown, PA. The private company specializes in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs. KVK-Tech handles all aspects of the manufacturing process, including packaging, distribution, research and development, and customer service. The company's portfolio includes a range of generic drugs that are chemically identical to branded drugs and must meet the same strict standards to receive FDA approval. KVK-Tech has a vision for 2020 to manufacture high-quality, affordable generics in every major dosage form. The CEO of the company is Anthony Tabasso. | Chief Operating Officer | 01.10.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
KRYSTAL BIOTECH, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
KVK-Tech, Inc.
KVK-Tech, Inc. Pharmaceuticals: MajorHealth Technology KVK-Tech, Inc. is a pharmaceutical company based in the United States, specifically in Newtown, PA. The private company specializes in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs. KVK-Tech handles all aspects of the manufacturing process, including packaging, distribution, research and development, and customer service. The company's portfolio includes a range of generic drugs that are chemically identical to branded drugs and must meet the same strict standards to receive FDA approval. KVK-Tech has a vision for 2020 to manufacture high-quality, affordable generics in every major dosage form. The CEO of the company is Anthony Tabasso. | Health Technology |